Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hematologic Malignancies
•
Medical Oncology
•
Myeloma
•
Hematology
What is your preferred dose and schedule for maintenance drugs post autoHCT for newly diagnosed multiple myeloma?
Related Questions
How would you approach management and monitoring of AL amyloidosis with isolated renal involvement?
What is your re-immunization strategy after auto SCT for patients with myeloma on dara/len maintenance?
What is your approach to bone imaging in MGUS?
In a patient with cardiac light chain amyloid who has significant heart failure symptoms, including inotrope dependence at presentation, how much clinical benefit does treatment provide?
How do you approach the second-line treatment for a patient with high-risk myeloma relapse early post-autoHCT after Dara-RVD induction?
How would you treat a stage I fully resected double hit DLBCL?
Would you consider pursuing renal transplantation in a patient with multiple myeloma?
How will you utilize the PARADIGM study results from ASH 2025, comparing azacitidine/venetoclax to intensive induction chemotherapy for fit patients with newly diagnosed AML?
Are there specific findings that would make you suspicious of IgD or IgE monoclonal gammopathies?
Is obinutuzumab obligatory with AV combination for patients with unmutated IGHV?
